Pulmonx Corporation

Pulmonx Corporationverified

LUNG

Price:

$7.31

Market Cap:

$286.21M

Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also provides StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help iden...[Read more]

Industry

Medical - Devices

IPO Date

2020-10-01

Stock Exchange

NASDAQ

Ticker

LUNG

The Enterprise Value as of September 2024 (TTM) for Pulmonx Corporation (LUNG) is 278.67M

According to Pulmonx Corporation’s latest financial reports and current stock price. The company's current Enterprise Value is 278.67M. This represents a change of -17.21% compared to the average of 336.60M of the last 4 quarters.

Pulmonx Corporation (LUNG) Historical Enterprise Value (quarterly & annually)

How has LUNG Enterprise Value performed in the past?

The mean historical Enterprise Value of Pulmonx Corporation over the last ten years is 1.04B. The current 278.67M Enterprise Value has changed 2.59% with respect to the historical average. Over the past ten years (40 quarters), LUNG's Enterprise Value was at its highest in in the December 2020 quarter at 2.14B. The Enterprise Value was at its lowest in in the June 2019 quarter at 0.

Quarterly (TTM)
Annual

Average

1.04B

Median

940.10M

Minimum

235.39M

Maximum

2.26B

Pulmonx Corporation (LUNG) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Pulmonx Corporation Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 87.70%

Maximum Annual Enterprise Value = 2.26B

Minimum Annual Increase = -77.29%

Minimum Annual Enterprise Value = 235.39M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2023441.82M87.70%
2022235.39M-77.29%
20211.04B-54.12%
20202.26B61.42%
20191.40B65.92%

Pulmonx Corporation (LUNG) Average Enterprise Value

How has LUNG Enterprise Value performed in the past?

The current Enterprise Value of Pulmonx Corporation (LUNG) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

571.29M

5-year avg

1.07B

10-year avg

1.04B

Pulmonx Corporation (LUNG) Enterprise Value vs. Peers

How is LUNG’s Enterprise Value compared to its peers?

Pulmonx Corporation’s Enterprise Value is less than IRadimed Corporation (520.58M), less than Orthofix Medical Inc. (747.43M), greater than NeuroPace, Inc. (271.03M), less than Integer Holdings Corporation (5.50B), less than NuVasive, Inc. (2.91B), less than CONMED Corporation (3.22B), less than OrthoPediatrics Corp. (725.14M), less than SI-BONE, Inc. (646.09M), less than RxSight, Inc. (2.09B), less than AxoGen, Inc. (614.50M), less than Treace Medical Concepts, Inc. (383.15M), greater than ProSomnus, Inc. Common Stock (40.81M), less than LivaNova PLC (2.60B), greater than Electromed, Inc. (133.03M), less than Surmodics, Inc. (563.14M), greater than Inogen, Inc. (187.98M), greater than Apyx Medical Corporation (51.06M),

Build a custom stock screener for Pulmonx Corporation (LUNG) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pulmonx Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Pulmonx Corporation (LUNG) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Pulmonx Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Pulmonx Corporation's Enterprise Value?

What is the highest Enterprise Value for Pulmonx Corporation (LUNG)?

What is the 3-year average Enterprise Value for Pulmonx Corporation (LUNG)?

What is the 5-year average Enterprise Value for Pulmonx Corporation (LUNG)?

How does the current Enterprise Value for Pulmonx Corporation (LUNG) compare to its historical average?